Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.
<h4>Background</h4>We undertook a study to evaluate the clinical relevance of miR-92a in plasma obtained from non-Hodgkin's lymphoma (NHL) patients, because the miR-17-92 polycistronic miRNA cluster plays a crucial role in lymphomagenesis and affects neo-angiogenesis.<h4>Metho...
Enregistré dans:
Auteurs principaux: | Kazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, Yoshikazu Ito, Michiyo Ohyashiki, Hisashi Kawashima, Masami Tanaka, Masahiko Kuroda, Junko H Ohyashiki |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e6082c2af40a4251a0de894f087ed976 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.
par: Masami Tanaka, et autres
Publié: (2009) -
Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
par: Esther K. Elliott, et autres
Publié: (2021) -
Hodgkin's lymphoma
par: E. A. Demina, et autres
Publié: (2020) -
Current advances in Hodgkin’s lymphoma
par: Joseph Vadakara, et autres
Publié: (2019) -
MEDICAL TREATMENT IN HODGKIN LYMPHOMA
par: Nilgun Kurucu
Publié: (2021)